| Literature DB >> 35668871 |
Jennifer J Beck1, Connor M Carpenter2, Nicole West1, Meagan J Sabatino2, Henry B Ellis2,3.
Abstract
Background: Isolated pediatric lateral ankle injuries, including ankle sprain (AS) and nondisplaced Salter-Harris type 1 (SH-1) distal fibular fracture, are common orthopaedic sports-related injuries. Variability in treatment is suspected among pediatric orthopaedic surgeons. Complications from medical treatment or lack thereof have not been reported in this population. Purpose: The purpose of this study was to investigate treatment variability and associated complications after pediatric AS and SH-1 via a survey of members of the Pediatric Orthopaedic Society of North American (POSNA). Study Design: Cross-sectional study. Level of evidence, 5.Entities:
Keywords: Salter-Harris lateral malleolar fracture; ankle sprains; complications; pediatric lateral ankle injury
Year: 2022 PMID: 35668871 PMCID: PMC9163735 DOI: 10.1177/23259671221100223
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Characteristics of the Survey Respondents (N = 229)
| Variable | Value |
|---|---|
| Age, y, mean (range) | 49.9 (31-82) |
| Female sex | 55 (24.0) |
| Years in practice, mean (range) | 16.9 (1-49) |
| Region of practice | |
| South | 80 (34.9) |
| Midwest | 54 (23.6) |
| West | 39 (17.0) |
| East | 37 (16.2) |
| Practice type | |
| Academic pediatric hospital | 116 (50.7) |
| Larger academic hospital | 35 (15.3) |
| Smaller, specialty-specific private practice | 27 (11.8) |
| Larger, multidisciplinary private practice | 17 (7.4) |
| Private pediatric hospital | 14 (6.1) |
| Solo practitioner | 11 (4.8) |
| Other | 9 (3.9) |
Data are reported as No. of respondents (%) unless otherwise noted.
Missing data from 19 participants.
Responses Regarding Clinical Diagnosis of Ankle Sprain Versus Salter-Harris Type 1 Injury
| How Do You Determine Ankle Sprain Versus Salter-Harris Type 1 Distal Fibular Fracture in a Skeletally Immature Patient? | |
|---|---|
| Physical examination only | 59 (25.7) |
| Physical examination and baseline radiograph | 88 (34.4) |
| Physical examination, baseline radiograph, and serial radiograph | 43 (18.7) |
| Magnetic resonance imaging (with and without physical examination) | 5 (2.2) |
| Ultrasonography (with and without physical examination) | 2 (0.9) |
Data are reported as No. of respondents (%).
Responses Regarding the Evaluation and Treatment of a First-Time Ankle Sprain or Salter-Harris Type 1 Injury
| Ankle Sprain | Salter-Harris Type 1 |
| |
|---|---|---|---|
| Preferred treatment | |||
| Physical therapy | 75 (32.8) | 26 (11.4) |
|
| Crutches | 79 (34.5) | 74 (32.3) | .52 |
| Isolated crutches | 12 (5.2) | 6 (2.6) | .15 |
| Immobilization | 179 (78.2) | 217 (94.8) |
|
| Isolated immobilization | 85 (37.1) | 135 (59.0) |
|
| Weightbearing status |
| ||
| Nonweightbearing | 3 (1.3) | 10 (4.4) | |
| Touch-down weightbearing | 1 (0.4) | 10 (4.4) | |
| Weightbearing as tolerated | 224 (98.2) | 209 (91.3) | |
| Preferred immobilization |
| ||
| Brace | 76 (33.5) | 19 (8.4) | |
| Controlled ankle motion boot | 105 (46.3) | 125 (55.6) | |
| Cast | 25 (11.0) | 78 (34.7) | |
| Nothing | 21 (9.3) | 3 (1.3) | |
| Return to play |
| ||
| 1-2 wk | 19 (9.5) | 1 (0.5) | |
| 3-4 wk | 121 (60.2) | 78 (38.6) | |
| 5-6 wk | 46 (22.9) | 97 (48.0) | |
| 7-8 wk | 8 (4.0) | 21 (10.4) | |
| >8 wk | 7 (3.5) | 5 (2.5) |
Data are reported as No. of respondents (%). Boldface P values indicate statistically significant difference between groups (P < .05).
Treatment Variation by Respondent Sex
| Ankle Sprain | Salter-Harris Type 1 | |||||
|---|---|---|---|---|---|---|
| Female | Male |
| Female | Male |
| |
| Primary treatment | ||||||
| Physical therapy | 26 (47.3) | 49 (28.7) |
| 11 (20.0) | 15 (8.8) |
|
| Crutches | 15 (27.3) | 64 (37.4) | .17 | 20 (36.4) | 54 (31.6) | .51 |
| Isolated crutches | 1 (1.8) | 11 (6.4) | .39 | 0 (0.0) | 6 (3.5) | .34 |
| Immobilization | 47 (85.5) | 129 (75.4) | .12 | 55 (100.0) | 159 (93.0) |
|
| Isolated immobilization | 19 (34.5) | 63 (36.8) | .75 | 28 (50.9) | 104 (60.8) | .19 |
| Weightbearing status | ||||||
| As tolerated | 54 (100.0) | 167 (97.7) | .51 | 51 (92.7) | 155 (90.6) | .59 |
| Toe-touch | 0 (0.0) | 1 (0.6) | 3 (5.5) | 7 (4.1) | ||
| Nonweightbearing | 0 (0.0) | 3 (1.8) | 1 (1.8) | 9 (5.3) | ||
Data are reported as No. of respondents (%). Boldface P values indicate statistically significant difference between groups (P < .05).
Treatment Variation by Respondent Age
| Ankle Sprain | Salter-Harris Type 1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 30s | 40s | 50s | ≥60 y |
| 30s | 40s | 50s | ≥60 y |
| |
| Primary treatment | ||||||||||
| Physical therapy | 27 (47.4) | 21 (31.3) | 15 (30.6) | 12 (21.4) |
| 8 (14.0) | 7 (10.4) | 8 (16.3) | 3 (5.4) | .30 |
| Crutches | 19 (33.3) | 18 (26.9) | 19 (38.8) | 23 (41.1) | .36 | 20 (35.1) | 20 (29.9) | 17 (34.7) | 17 (30.4) | .89 |
| Isolated crutches | 4 (7.0) | 4 (6.0) | 1 (2.0) | 3 (5.4) | .71 | 1 (1.8) | 1 (1.5) | 0 (0.0) | 4 (7.1) | .14 |
| Immobilization | 39 (68.4) | 53 (79.1) | 44 (89.8) | 43 (76.8) | .07 | 55 (96.5) | 64 (95.5) | 47 (95.9) | 51 (91.1) | .63 |
| Isolated immobilization | 19 (33.3) | 26 (38.8) | 16 (32.7) | 24 (42.9) | .65 | 32 (56.1) | 42 (62.7) | 24 (49.0) | 37 (66.1) | .29 |
| Weightbearing status | .33 | .62 | ||||||||
| As tolerated | 57 (100.0) | 66 (98.5) | 49 (100.0) | 52 (94.5) | 50 (87.7) | 61 (91.0) | 46 (93.9) | 52 (92.9) | ||
| Toe-touch | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.8) | 5 (8.8) | 2 (3.0) | 2 (4.1) | 1 (1.8) | ||
| Nonweightbearing | 0 (0.0) | 1 (1.5) | 0 (0.0) | 2 (3.6) | 2 (3.5) | 4 (6.0) | 1 (2.0) | 3 (5.1) | ||
Data are reported as No. of respondents (%). Boldface P value indicates statistically significant difference between groups (P < .05).
Variation in Type of Immobilization According to Respondent Characteristics
| Ankle Sprain | Salter-Harris Type 1 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cast | CAM Boot | Brace | Nothing |
| Cast | CAM Boot | Brace | Nothing |
| |
| Overall | 25 (11.0) | 105 (46.3) | 76 (33.5) | 21 (9.3) | 78 (34.7) | 125 (55.6) | 19 (8.4) | 3 (1.3) | ||
| Sex | .46 | .89 | ||||||||
| Female | 7 (13.0) | 28 (51.9) | 16 (29.6) | 3 (5.6) | 20 (37.0) | 31 (57.4) | 3 (5.6) | 0 (0.0) | ||
| Male | 17 (10.0) | 75 (44.1) | 60 (35.3) | 18 (10.6) | 57 (33.9) | 92 (54.8) | 16 (9.5) | 3 (1.8) | ||
| Age | .16 |
| ||||||||
| 30s | 4 (7.0) | 26 (45.6) | 20 (35.1) | 7 (12.3) | 14 (24.6) | 39 (68.4) | 3 (5.3) | 1 (1.8) | ||
| 40s | 10 (15.4) | 34 (52.3) | 15 (23.1) | 6 (9.2) | 26 (40.6) | 34 (53.1) | 2 (3.1) | 2 (3.1) | ||
| 50s | 4 (8.2) | 27 (55.1) | 14 (28.6) | 4 (8.2) | 14 (29.2) | 29 (60.4) | 5 (10.4) | 0 (0.0) | ||
| ≥60 y | 7 (12.5) | 18 (32.1) | 27 (48.2) | 4 (7.1) | 24 (42.9) | 23 (41.1) | 9 (16.1) | 0 (0.0) | ||
| Region | .36 | .26 | ||||||||
| East | 2 (5.4) | 20 (54.1) | 12 (32.4) | 3 (8.1) | 8 (21.6) | 22 (59.5) | 7 (18.9) | 0 (0.0) | ||
| Midwest | 3 (5.6) | 30 (55.6) | 17 (31.5) | 4 (7.4) | 16 (30.2) | 34 (64.2) | 2 (3.8) | 1 (1.9) | ||
| South | 12 (15.2) | 36 (45.6) | 22 (27.8) | 9 (11.4) | 29 (36.7) | 44 (55.7) | 5 (6.3) | 1 (1.3) | ||
| West | 5 (12.8) | 14 (35.9) | 18 (46.2) | 2 (5.1) | 15 (39.5) | 21 (55.3) | 2 (5.3) | 0 (0.0) | ||
| Institution type | .48 | .71 | ||||||||
| Academic hospital | 14 (9.3) | 69 (46.0) | 50 (33.3) | 17 (11.3) | 47 (31.8) | 86 (58.1) | 13 (8.8) | 2 (1.4) | ||
| Private/solo practice | 8 (11.8) | 32 (47.1) | 24 (35.3) | 4 (5.9) | 25 (36.8) | 36 (52.9) | 6 (8.8) | 1 (1.5) | ||
| Practice volume |
| .07 | ||||||||
| High (≥10) | 16 (14.8) | 41 (38.0) | 43 (39.8) | 8 (7.4) | 45 (42.1) | 50 (46.7) | 10 (9.3) | 2 (1.9) | ||
| Low (<10) | 9 (7.6) | 64 (53.8) | 33 (27.7) | 13 (10.9) | 33 (28.0) | 75 (63.6) | 9 (7.6) | 1 (0.8) | ||
Data are reported as No. of respondents (%). Boldface P values indicate statistically significant difference between groups (P < .05). CAM, controlled ankle motion.
Number of low-energy lateral ankle injuries treated annually.
Variation in Return-to-Play Times According to Respondent Characteristics
| Ankle Sprain | Salter-Harris Type 1 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-2 wk | 3-4 wk | 5-6 wk | 7-8 wk | >8 wk |
| 1-2 wk | 3-4 wk | 5-6 wk | 7-8 wk | >8 wk |
| |
| Overall | 19 (9.5) | 121 (60.2) | 46 (22.9) | 8 (4.0) | 7 (3.5) | 1 (0.5) | 78 (38.6) | 97 (48.0) | 21 (10.4) | 5 (2.5) | ||
| Sex | .16 | .95 | ||||||||||
| Female | 7 (16.7) | 21 (50.0) | 12 (28.6) | 2 (4.8) | 0 (0.0) | 0 (0.0) | 15 (34.9) | 22 (51.2) | 5 (11.6) | 1 (2.3) | ||
| Male | 12 (7.7) | 98 (62.8) | 33 (21.2) | 6 (3.8) | 7 (4.5) | 1 (0.6) | 61 (38.9) | 75 (47.8) | 16 (10.2) | 4 (2.5) | ||
| Age | .78 | .53 | ||||||||||
| 30s | 5 (9.6) | 33 (63.5) | 9 (17.3) | 3 (5.8) | 2 (3.8) | 1 (2.0) | 16 (31.4) | 26 (51.0) | 8 (15.7) | 0 (0.0) | ||
| 40s | 6 (10.3) | 35 (60.3) | 14 (24.1) | 1 (1.7) | 2 (3.4) | 0 (0.0) | 28 (47.5) | 25 (42.4) | 4 (6.8) | 2 (3.4) | ||
| 50s | 3 (7.3) | 24 (58.5) | 9 (22.0) | 4 (9.8) | 1 (2.4) | 0 (0.0) | 17 (39.5) | 19 (44.2) | 5 (11.6) | 2 (4.7) | ||
| ≥60 y | 5 (10.0) | 29 (58.0) | 14 (28.0) | 0 (0.0) | 2 (4.0) | 0 (0.0) | 17 (35.9) | 27 (53.8) | 4 (7.7) | 1 (2.6) | ||
| Region | .47 | .21 | ||||||||||
| East | 4 (11.1) | 21 (58.3) | 10 (27.8) | 1 (2.8) | 0 (0.0) | 0 (0.0) | 17 (48.6) | 14 (40.0) | 4 (11.4) | 0 (0.0) | ||
| Midwest | 6 (13.0) | 26 (56.5) | 9 (19.6) | 4 (8.7) | 1 (2.2) | 0 (0.0) | 15 (34.1) | 22 (50.0) | 5 (11.4) | 2 (4.5) | ||
| South | 7 (10.0) | 46 (65.7) | 15 (21.4) | 0 (0.0) | 2 (2.9) | 1 (1.4) | 31 (42.5) | 38 (52.1) | 3 (4.1) | 0 (0.0) | ||
| West | 2 (5.9) | 19 (55.9) | 9 (26.5) | 3 (8.8) | 1 (2.9) | 0 (0.0) | 10 (29.4) | 17 (50.0) | 6 (17.6) | 1 (2.9) | ||
| Institution type |
| .44 | ||||||||||
| Academic hospital | 8 (6.0) | 80 (60.2) | 32 (24.1) | 8 (6.0) | 5 (3.8) | 1 (1.0) | 49 (32.4) | 65 (49.5) | 16 (14.3) | 4 (2.9) | ||
| Private/solo practice | 10 (15.9) | 40 (63.5) | 13 (20.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 28 (44.4) | 31 (49.2) | 4 (6.3) | 0 (0.0) | ||
| Practice volume | .07 | .65 | ||||||||||
| High (≥10) | 14 (14.9) | 55 (58.5) | 21 (22.3) | 3 (3.2) | 1 (1.1) | 0 (0.0) | 39 (40.2) | 48 (49.5) | 9 (9.3) | 1 (1.0) | ||
| Low (<10) | 5 (4.7) | 66 (61.7) | 25 (23.4) | 5 (4.7) | 6 (5.6) | 1 (1.0) | 39 (37.1) | 49 (46.7) | 12 (11.4) | 4 (3.8) | ||
Data are reported as No. of respondents (%). Boldface P value indicates statistically significant difference between groups (P < .05).
Injury-Related Complications Reported During Treatment
| Ankle Sprain | Salter-Harris Type 1 | |
|---|---|---|
| Persistent pain/reflex sympathetic dystrophy | 12 (5.2) | 16 (7.0) |
| Growth disturbance | 1 (0.4) | 12 (5.2) |
| Prolonged healing/recurrent injury | 4 (1.7) | 3 (1.3) |
| Infection | 0 (0.0) | 1 (0.4) |
Data are reported as No. of respondents (%).
Treatment-Related Complications
| Ankle Sprain | Salter-Harris Type 1 | |
|---|---|---|
| No complications reported | 201 (87.8) | 186 (81.2) |
| Other complication | 15 (6.6) | 20 (8.7) |
| Cast complication, brace complication, other complication | 4 (1.7) | 4 (1.8) |
| Cast complication | 3 (1.3) | 6 (2.6) |
| Cast complication, other complication | 3 (1.3) | 11 (4.8) |
| Cast complication, brace complication | 2 (0.9) | 1 (0.4) |
| Brace complication | 1 (0.4) | 1 (0.4) |
Data are reported as No. of respondents (%).
Complications Due to Neglected Treatment
| Ankle Sprain | Salter-Harris Type 1 | |
|---|---|---|
| Fracture displacement | 1 (0.4) | 5 (2.2) |
| Nonunion | 1 (0.4) | 10 (4.4) |
| Growth disturbance | 0 (0.0) | 4 (1.7) |
| Pain | 11 (4.8) | 11 (4.8) |
| Wounds | 0 (0.0) | 1 (0.4) |
Data are reported as No. of respondents (%).
Patient developed osteochondritis dissecans after ankle sprain.